Abstract
The hypothalamic-pituitary-adrenal (HPA) axis is one of the most important allostatic systems that allow a person to respond and adapt against diverse stresses by upregulating the glucocorticoids and adrenal androgens. However, its inhibition is equally important to prevent against deleterious effect of its overexposure to neuroendocrine and inflammatory stresses. This chapter aims to examine the effect of stress and aging on the dysregulation of the HPA axis. Chronic stress and aging are phenomenons that have complex interaction at the level of HPA axis; while chronic stress promotes aging, consequently aging leads to dysregulated stress management. The effects of the terminal regulators of the HPA axis like glucocorticosteroids (GCs; cortisol) and adrenal androgens (DHEA and its sulfate; DHEAS) are drastically opposite; while cortisol promotes neuronal cell death and degeneration, DHEAS plays protective role against neuronal impairment. With age there is a marked increase in the nocturnal as well as 24 h circulating cortisol secretion accompanied by clear flattening of the diurnal rhythm of cortisol secretion evident from both animal and human studies. Also, there is a clear dysregulation of the negative feedback inhibition of the GC secretion in chronic stress and aging. Besides, the androgenic steroids like DHEA/DHEAS secreted in response to ACTH also undergo marked depreciation in elderly subjects. Consequently, there is a marked increase in the cortisol/DHEAS molar ratio with physiological and pathological aging. Hence, the dysregulation in these two classes of steroids with aging and chronic stress and their manifestations are examined in detail in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hall JE. (2011) Guyton and Hall text book of medical physiology, 12th ed. Saunders Elsevier, chapters 74 & 75, pp 881–904
Johnson G, Singer S, Losos J and Raven P. (2003) Raven Johnson biology, 6th ed. The McGraw-Hill Companies, chapter 56, pp 1125–1146
Dunn JH, Koo J (2013) Psychological stress and skin aging: a review of possible mechanisms and potential therapies. Dermatol Online J 19(6):1
Shagan BP (1976) Is diabetes a model for aging? Med Clin North Am 60(6):1209–1211
Cerami A (1985) Hypothesis. Glucose as a mediator of aging. J Am Geriatr Soc 33(9):626–634
Mooradian AD (1988) Tissue specificity of premature aging in diabetes mellitus. The role of cellular replicative capacity. J Am Geriatr Soc 36(9):831–839
Goto M (2008) Inflammaging [inflammation + aging]: a driving force for human aging based on an evolutionarily antagonistic pleiotropy theory? Biosci Trends 2(6):218–230
Pincus T, Sokka T, Wolfe F (2001) Premature mortality in patients with rheumatoid arthritis: evolving concepts. Arthritis Rheum 44(6):1234–1236
Navarro-Cano G, Del Rincón I, Pogosian S, Roldán JF, Escalante A (2003) Association of mortality with disease severity in rheumatoid arthritis, independent of comorbidity. Arthritis Rheum 48(9):2425–2433
Sokka T, Abelson B, Pincus T (2008) Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 26(5 Suppl 51):S35–S61
Gonzalez A, Maradit Kremers H, Crowson CS, Nicola PJ, Davis JM, Therneau TM, Roger VL, Gabriel SE (2007) The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 56(11):3583–3587
Gupta D, Morley JE (2014) Hypothalamic-Pituitary-Adrenal (HPA) axis and aging. Compr Physiol 4:1495–1510
McClintock D, Ratner D, Lokuge M, Owens DM, Gordon LB, Collins FS and Djabali K. (2007) The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin. PLoS One 2(12):e1269. PubMed PMID: 18060063; PubMed Central PMCID: PMCPMC2092390
Korf B (2008) Hutchinson-Gilford progeria syndrome, aging, and the nuclear lamina. N Engl J Med 358(6):552–555
Ulrich-Lai YM, Ryan KK (2013) PPARγ and stress: implications for aging. Exp Gerontol 48(7):671–676
Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, Yankner BA (2004) Gene regulation and DNA damage in the ageing human brain. Nature 429(6994):883–891
Groeschel M, Braam B (2011) Connecting chronic and recurrent stress to vascular dysfunction: no relaxed role for the renin-angiotensin system. Am J Physiol Renal Physiol 300(1):F1–F10
Flint MS, Budiu RA, Teng PN, Sun M, Stolz DB, Lang M, Hood BL, Vlad AM, Conrads TP (2011) Restraint stress and stress hormones significantly impact T lymphocyte migration and function through specific alterations of the actin cytoskeleton. Brain Behav Immun 25(6):1187–1196
Wise PM, Herman JP, Landfield PW (1997) Neuroendocrine aspects of the aging brain. In: Timiras PS, Bittar EE, Mattson MP, Geddes JW (eds) Advances in cell aging and gerontology. JAI Press Inc., London, pp 193–241
Aguilera G (2011) HPA axis responsiveness to stress: implications for healthy aging. Exp Gerontol 46:90–95. [PubMed: 20833240]
Garrido P (2011) Aging and stress: past hypotheses, present approaches and perspectives. Aging Dis 2:80–99. [PubMed: 22396868]
Chung HY, Sung B, Jung KJ, Zou Y, Yu BP (2006) The molecular inflammatory process in aging. Antioxid Redox Signal 8(3–4):572–581
Plotsky PM, Otto S, Sapolsky RM (1986) Inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation by delayed glucocorticoid feedback. Endocrinology 119(3):1126–1130
Antoni FA (1986) Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 7:351–378
Taylor AL, Fishman LM (1988) Cortocotropin-releasing hormone. N Engl J Med 319:213–222
Donald RA (1980) ACTH and related peptides. Clin Endocrinol 12:491–524
Smith AI, Funder JW (1988) Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr Rev 9:159–179
Chen R, Lewis KA, Perrin MH, Vale WW (1993) Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci U S A 90:8967–8971
Hauger RL, Aguilera G (1993) Regulation of pituitary corticotropin releasing hormone (CRH) receptors by CRH: interaction with vasopressin. Endocrinology 133:1708–1714
Bateman A, Singh A, Kral T, Solomon S (1989) The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev 10:92–112
Chrousos GP (1995) The hypothalamic-pituitary-adrenal axis and immunemediated inflammation. N Engl J Med 332:1351–1362
Mountjoy KG, Robbins LS, Mortrud MT, Cone RD (1992) The cloning of a family of genes that encode the melanocortin receptors. Science 257:1248–1251
Simpson ER, Waterman MR (1988) Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH. Annu Rev Physiol 50:427–440
Stocco DM, Clark BJ (1996) Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev 17:221–244
Waterman MR, Bishoff LJ (1997) Cytochromes P450 12: diversity of ACTH (cAMP)-dependent transcription of bovine steroid hydroxylase genes. FASEB J 11:419–427
Veldhuis JD (2013) Changes in pituitary function with aging and implications for patient care. Nat Rev Endocrinol 9(4):205–215
Reiter RJ (1995) The pineal gland and melatonin in relation to aging: a summary of the theories and of the data. Exp Gerontol 30(3/4):199–212
Hoehn K, Marieb EN (2010) Human Anatomy & Physiology, 8th edn. Benjamin Cummings, San Francisco. ISBN 0-321-60261-7
Coderre L, Srivastava AK, Chiasson JL (1991) Role of glucocorticoid in the regulation of glycogen metabolism in skeletal muscle. Am J Phys 260(6 Pt 1):E927–E932
Simmons PS, Miles JM, Gerich JE, Haymond MW (1984) Increased proteolysis. An effect of increases in plasma cortisol within the physiologic range. J Clin Invest 73(2):412–420
Hornsby PJ (1997) DHEA: a biologist’s perspective. J Am Geriatr Soc 45:1395–1401
Guillemette C, Hum DW, Belanger A (1996) Levels of plasma C19 steroids and 5-alpha-reduced C19 steroid glucuronides in primates, rodents, and domestic animals. Am J Physiol 271:E348–E353
Endoh A, Kristiansen SB, Casson PR, Busters JE, Hornsby PJ (1996) The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex, resulting from its low expression of 3 beta-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab 81:3558–3565
Pescovitz OH, Eugster EA (2004) Pediatric endocrinology: mechanisms, manifestations, and management. Lippincott Williams & Wilkins, pp 362–. ISBN 978-0-7817-4059-3
Lifshitz F (2006) Pediatric endocrinology: growth, adrenal, sexual, thyroid, calcium, and fluid balance disorders. CRC Press, pp 289–. ISBN 978-1-4200-4272-6
Salhan S (2011) Textbook of gynecology. JP Medical Ltd., pp 94–. ISBN 978-93-5025-369-4
Ferrari E, Cravello L, Muzzoni B, Casarotti D, Paltro M, Solerte SB, Fioravanti M, Cuzzoni G, Pontiggia B, Magri F (2001) Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates. Eur J Endocrinol 144:319–329. [PubMed: 11275940]
Thomas G, Frenoy N, Legrain S, Sebag-Lanoe R, Baulieu EE, Debuire B (1994) Serum dehydroepiandrosterone sulfate levels as an individual marker. J Clin Endocrinol Metab 79:1273–1276
Labrie F, Belanger A, Cusan L, Gomez JL, Candas B (1997) Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 82:2396–2402
Labrie F, Belanger A, Simard J, Luu-The V, Labrie C (1995) DHEA and peripheral androgen and estrogen formation: Intracrinology. Ann N Y Acad Sci 774:16–28
Labrie F, Dupont A, Belanger A (1985) Complete androgen blockade for the treatment of prostate cancer. Important Adv Oncol 1985:193–217
Labrie F (1991) Intracrinology. Mol Cell Endocrinol 78:C113–C118
Chen F, Knecht K, Birzin E, Fisher J, Wilkinson H, Mojena M, Moreno CT, Schmidt A, Harada S, Freedman LP, Reszka AA (2005) Direct agonist/antagonist functions of dehydroepiandrosterone. Endocrinology 146(11):4568–4576
Gao W, Bohl CE, Dalton JT (2005) Chemistry and structural biology of androgen receptor. Chem Rev 105(9):3352–3370. PMC 2096617
Webb SJ, Geoghegan TE, Prough RA, Michael Miller KK (2006) The biological actions of dehydroepiandrosterone involves multiple receptors. Drug Metab Rev 38(1–2):89–116. PMC 2423429
Peters JM, Zhou YC, Ram PA, Lee SS, Gonzales FJ, Waxman DJ (1996) Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3beta-sulfate. Mol Pharmacol 50:67–74
Abadie J, Wright B, Correa G, Browne ES, Porter JR, Swec F (1993) Effects of dehydroepiandrosterone on neurotransmitter levels and appetite regulation of the obese Zucker rat. Diabetes 42:662–669
Yoo A, Harris J, Dubrovsky B (1996) Dose-response study of dehydroepiandrosterone sulfate on dentate gyrus long-term potentiation. Exp Neurol 137:151–156
McGaugh JL (2004) The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci 27:1–28
Phelps EA, LeDoux JE (2005) Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 48:175–187
Sanders MJ, Siltgen BJ, Fanselow MS (2003) The place of the hippocampus in fear conditioning. Eur J Pharmacol 463:217–223
Leproult R, Copinschi G, Buxton O, Van Cauter E (1997) Sleep loss results in an elevation of cortisol levels the next evening. Sleep 20(10):865–870
Silverman MN, Pearce BD, Biron CA, Miller AH (2005) Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol 18(1):41–78
Fuchs E, Flugge G (2003) Chronic social stress effects on limbic brain structures. Physiol Behav 79:417–427
Herman JP, Seroogy K (2006) Hypothalamic-pituitary-adrenal axis glucocorticoids and neurologic disease. Neurol Clin 24:461–481
de Kloet ER, Joels M, Holsboer F (2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6:463–475
Dek Michalska AG, Spyrka J, Rachwalska P, Tadeusz J, Bugajski J (2013) Influence of chronic stress on brain corticosteroid receptors and HPA axis activity. Pharmacol Rep 65:1163–1175
Silverman MN, Sternberg EM (2012) Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci 1261:55–63
Dallman MF, Levin N, Cascio CS, Akana SF, Jacobson L, Kuhn RW (1989) Pharmacological evidence that the inhibition of diurnal adrenocorticotropin secretion by corticosteroids is mediated via type I corticosterone-preferring receptors. Endocrinology 124:2844–2850
de Kloet ER, Vreugdehil E, Oitzl MS, Joels M (1998) Brain corticosteroid receptor balance in health and disease. Endocr Rev 9:269–301
Reul JMHM, de Kloet ER (1985) Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117:2505–2511
Noordam R, Jansen SW, Akintola AA, Oei NY, Maier AB, Pijl H, Slagboom PE, Westendorp RG, van der Goud J, de Craen AJ, van Heemst D (2012) Leiden longevity study group. Familial longevity is marked by lower diurnal salivary cortisol levels: the Leiden longevity study. PLoS ONE 7:e31166
Mikics E, Kruk MR, Haller J (2004) Genomic and non-genomic effects of glucocorticoids on aggressive behavior in male rats. Psychoneuroendocrinology 29:618–635
Sandi C, Venero C, Guaza C (1996) Novelty-related rapid locomotor effects of corticosterone in rats. Eur J Neurosci 8:794–800
Joels M, Karst H, de Rijk RH, de Kloet ER (2008) The coming out of the brain mineralocorticoid receptor. Trends Neurosci 31:1–7
Karst H, Berger S, Turiault M, Tronche F, Schutz G, Joels M (2005) Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc Natl Acad Sci 102:19204–19207
Tasker JG, Di S, Malcher-Lopes R (2006) Minireview: rapid glucocorticoid signaling via membrane-associated receptors. Endocrinology 147:5549–5556
Dong Y, Poellinger L, Okret S, Hoog JO, von Bahr-Lindstrom H, Jornvall H, Gustafsson JA (1988) Regulation of gene expression of class I alcohol dehydrogenase by glucocorticoids. Proc Natl Acad Sci U S A 85:767–771
Jun SS, Chen Z, Pace MC, Shaul PW (1999) Glucocorticoids downregulate cyclooxygenase-1 gene expression and prostacyclin synthesis in fetal pulmonary artery endothelium. Circ Res 84:193–200
Morsink MC, Joels M, Sarabdjitsingh RA, Meijer OC, de Kloet ER, Datson NA (2006) The dynamic pattern of glucocorticoid receptor-mediated transcriptional responses in neuronal PC12 cells. J Neurochem 99:1282–1298
Morsink MC, Steenbergen PJ, Vos JB, Karst H, Joels M, de Kloet ER, Datson NA (2006) Acute activation of hippocampal glucocorticoid receptors results in different waves of gene expression throughout time. J Neuroendocrinol 18:239–252
Lundblad JR, Roberts JL (1988) Regulation of proopiomelanocortin gene expression in pituitary. Endocr Rev 9:135–158
Davis LG, Arentzen R, Reid JM, Manning RW, Wolfson B, Lawrence KL, Baldino F Jr (1986) Glucocorticoid sensitivity of vasopressin mRNA levels in the paraventricular nucleus of the rat. Proc Natl Acad Sci U S A 83: 1145–1149
Keller-Wood ME, Dallman MF. (1984) Corticosteroid inhibition of ACTH secretion. Endocr Rev 5: 1–24
Mizoguchi K, Ikeda R, Shoji H, Tanaka Y, Maruyama W, Tabira T (2009) Aging attenuates glucocorticoid negative feedback in rat brain. Neuroscience 159:259–270. [PubMed: 19141312]
Oitzl MS, Reichardt HM, Joels M, de Kloet ER (2001) Point mutation in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory. Proc Natl Acad Sci U S A 98:12790–12795
Ridder S, Chourbaji S, Hellweg R, Urani A, Zacher C, Schmid W, Zink M, Hortnagl H, Flor H, Henn FA, Schutz G, Gass P (2005) Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J Neurosci 25: 6245–6250
Berger S, Wolfer Dp, Selbach O, Alter H, Erdmann G, Reichardt HM, Chepkova AN, Welzl H, Haas HL, Lipp HP, Schutz G (2006) Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity. Proc Natl Acad Sci USA 103: 95–200
Lai M, Horsburgh K, Bae SE, Carter RN, Stenvers DJ, Fowler JH, Yau CE, Gomez-Sanchez CE, Holmes MC, Kenyon CJ, Seckl JR, MacLeod MR (2007) Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischemia. Eur J Neurosci 25:1832–1842
Rozeboom AM, Akil H, Seasholtz AF (2007) Mineralocorticoid receptor overexpression in forebrain decreases anxiety-like behavior and alters the stress response in mice. Proc Natl Acad Sci U S A 104:4688–4693
Kasckow J, Xiao C, Herman JP (2009) Glial glucocorticoid receptors in aged Fisher 344 (F344) and F344/Brown Norway rats. Exp Gerontol 44:335–343
Lee SY, Hwang YK, Yun HS, Han JS (2012) Decreased levels of nuclear glucocorticoid receptor protein in the hippocampus of aged Long-Evans rats with cognitive impairment. Brain Res 1478:48–54
Murphy EK, Spencer RL, Sipe KJ, Herman JP (2002) Decrements in nuclear glucocorticoid receptor (GR) protein levels and DNA binding in aged rate hippocampus. Endocrinology 143:1362–1370
Bizon JL, Helm KA, Han JS, Chun HJ, Pucilowska J, Lund PK, Gallagher M (2001) Hypothalamic-pituitary-adrenal axis function and corticosterone receptor expression in behaviourally characterized young and aged Long-Evans rats. Eur J Neurosci 14:1739–1751
Brudieux R, Ait Chaoui A, Rakotondrazafy J (1995) Age-related decreases in plasma adrenocorticotropic hormone, corticosterone, and aldosterone responses to exogenous corticotropin-releasing hormone in the rat. Gerontology 41:308–314
Dalm S, Enthoven L, Meijer OC, Van der Mark MH, Karssen AM, de Kloet ER, Oitzl MS (2005) Age-related changes in hypothalamic-pituitary-adrenal axis activity of male C57BL/6J mice. Neuroendocrinology 81:372–380
Hauger RLM, Thrivikraman KV, Plotsky PM (1994) Age-related alterations of hypothalamic-pituitary-adrenal axis function in male Fischer 344 rats. Endocrinology 134:1528–1536
Herman JP, Schafer MK, Young EA, Thompson R, Douglass J, Akil H, Watson SJ (1989) Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis. J Neurosci 9:3072–3082
Jӧels M, Krugers H, Karst H (2008) Stress-induced changes in hippocampal function. Prog Brain Res 167:3–15
Kant GF, Meyerhoff JL, Jarrard LE (1984) Biochemical indices of reactivity and habituation in rats with hippocampal lesions. Pharmacol Biochem Behav 20:793–797
Sapolsky RM, Romero LM, Munck AU (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21:55–89
Gardner MP, Lightman SL, Gallacher J, Hardy R, Kuh D, Ebrahim S, Boyer A, Ben-Shlomo Y (2011) Halcyon study team. Diurnal cortisol patterns are associated with physical performance in the Caerphilly prospective study. Int J Epidemiol 40:1693–1702
Gardner MP, Lightman S, Sayer AA, Coopoer C, Cooper R, Deeg D, Ebrahim S, Gallacher J, Kivimaki M, Kumari M, Kuh D, Rm M, Peeters G, Ben-Schlomo Y (2013) Halcyon study team. Dysregulation of the hypothalamic pituitary adrenal (HPA) axis and physical performance at older ages: an individual participant meta-analysis. Psychoneuroendocrinology 38:40–49
Hatzinger M, Reul JM, Landgraf R, Holsboer F, Neumann I (1996) Combined dexamethasone/CRH test in rats: hypothalamo-pituitary-adrenocortical system alterations in aging. Neuroendocrinology 64:349–356
Meaney MJ, Aitken DH (1985) Dexamethasone binding in rat frontal cortex. Brain Res 328:176–180
Veldhuis JD, Sharma A, Roelfsema F (2013) Age-dependent and genderdependent regulation of hypothalamic-adrenocorticotropic-adrenal axis. Endocrinol Metab Clin N Am 42:201–225
Purnell JQ, Brandon DD, Isabelle LM, Loriaux DL, Samuels MH (2004) Association of 24-hour cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. J Clin Endocrinol Metab 89:281–287
Milcu SM, Bogdan C, Nicolau GY, Cristea A (1978) Cortisol circadian rhythm in 70–100-year-old subjects. Endocrinologie 16: 29–39
Van Cauter E, Leproult R, Kupfer DJ (1996) Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 81:2468–2473
Barton RN, Horan MA, Clague JE, Rose JG (1999) The effect of aging on the metabolic clearance rate and distribution of cortisol in man. Arch Gerontol Geriatr 29:95–105
Barton RN, Horan MA, Weijers JW, Sakkee AN, Roberts NA, van Bezooijen CF (1993) Cortisol production rate and the urinary excretion of 17-hydroxycorticosteroids, free cortisol, and 6 beta-hydroxycortisol in healthy elderly men and women. J Gerontol 48:M213–M218
Nicolson N, Storms C, Ponds R, Sulon J (1997) Salivary cortisol levels and stress reactivity in human aging. Gerontol A Biol Sci Med Sci 52: M68–M75
Lupien S, Lecours AR, Lussoer I, Schwartz G, Nair NP, Meaney M (1994) Basal cortisol levels and cognitive deficits in human aging. J Neurosci 14:2893–2903
Lupien SJ, Fiocco A, Wan N, Maheu F, Lord C, Schramek T, Tu MT (2005) Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology 30:225–242
Giordono R, Bo M, Pallegrino M, Vessari M, Baldi M, Pieu A, Balbo M, Bonelli L, Migliaretti G, Ghigo E, Arvat E (2005) Hypothalamus-pituitary adrenal hyperactivity in human aging is partially refractory to stimulation by mineral corticoid receptor blockade. J Clin Endocrniol Metab 90:5656–5662
Buckley TM, Mullen BC, Schatzberg AF (2007) The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypo- thalamic adrenal-pituitary (HPA) axis activity in healthy controls. Psychoneuroendocrinology 32:859–864
Otte C, Jahn H, Yassourids A, Arlt J, Stober N, Maass P, Wiedemann K, Kellner M (2003) The mineral corticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone. Life Sci 73:1835–1845
Otte C, Yassouridis A, Jahn H, Maass P, Stober N, Wiedemann K, Kellner M (2003) Mineralocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in aged humans. J Gerontol A Biol Sci Med Sci 58:900–905
Morley JE. (2009) Developing novel therapeutic approaches to frailty. Curr Pharm Des 15:3384–3395
Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, Cesari M, Chumlea WC, Doehner W, Evans J, Fried LP, Guralnik JM, Katz PR, Malmstrom TK, McCarter RJ, Gutierrez-Robledo LM, Rockwood K, von Haehling S, Vandewoude MF, Walston J (2013) Frailty consensus: a call to action. J Am Med Dir Assoc 14:392–397
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA. (2001) Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156
Varadhan R, Walston J, Cappola AR, Carlson MC, Wand GS, Fried LP (2008) Higher levels and blunted diurnal variation of cortisol in frail older women. J Gerontol A Biol Sci Med Sci 63:190–195
Holanda CM, Guerra RO, Nobrega PV, Costa HF, Piuvezam MR, Maciel AC (2012) Salivary cortisol and frailty syndrome in elderly residents of long-stay institutions: a cross-sectional study. Arch Gerontol Geriatr 54:e146–e151
Gardner MP, Lightman SL, Gallacher J, Hardy R, Kuh D, Ebrahim S, Boyer A, Ben-Shlomo Y (2011) Halcyon study team. Diurnal cortisol patterns are associated with physical performance in the Caerphilly prospective study. Int J Epidemiol 40:1693–1702
Kumari M, Badrick E, Sacker A, Kirschbaum C, Marmot M, Chandola T (2010) Identifying patterns in cortisol secretion in an older population. Findings from the Whitehall II study. Psychoneuroendocrinology 35:1091–1099
Peeters GM, van Schoor NM, Visser M, Knol DL, Eekhoff EM, de Ronde W, Lips P (2007) Relationship between cortisol and physical performance in older persons. Clin Endocrinol 67:398–406
Heaney JL, Phillips AC, Carroll D (2012) Ageing, physical function, and the diurnal rhythms of cortisol and dehydroepiandrosterone. Psychoneuroendocrinology 37:341–349
Belanger A, Candas B, Dupont A, Cusan L, Diamond P, Gomez JL, Labrie F (1994) Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J Clin Endocrinol Metab 79:1086–1090
Labrie F, Belanger A, Cusan L, Gomez JL, Candas B (1997) Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 82:2396–2402
Havlikova H, Hill M, Hampl R and Starka L. (2002) Sex- and age-related changes in epitestosterone in relation to pregnenolone sulfate and testosterone in normal subjects. J Clin Endocrinol Metab 87: 2225–2231
Heaney JL, Phillips AC, Carroll D (2012) Ageing, physical function, and the diurnal rhythms of cortisol and dehydroepiandrosterone. Psychoneuroendocrinology 37(3):341–349
Ahn RS, Lee YJ, Choi JY, Kwon HB, Chun SI (2007) Salivary cortisol and DHEA levels in the Korean population: age-related differences, diurnal rhythm, and correlations with serum levels. Yonsei Med J 48:379–438
Parker CR, Mixon RL, Brissie RM, Grizzle WE (1997) Aging alters zonation in the adrenal cortex of men. J Clin Endocrinol Metab 82:3898–3901
Robel P, Baulieu EE (1995) Dehydroepiandrosterone (DHEA) is a neuractive neurosteroid. Annal New York Acad Sci 774:82–110
Baulieu EE. (1996) Dehydroepiandrosterone (DHEA): fountain of youth? J Clin Endocrinol Metab 81:3147–3151
McEwen BS (2003) Mood disorders and allostatic load. Biol Psychiatry 54:200–207
Morley JE, Kaiser F, Raum WJ, Perry HM III, Flood JF, Jensen J, Silver AJ, Roberts E (1997) Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc Natl Acad Sci U S A 94: 7537–7542
Liu D, Dillon JS (2002) Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3). J Biol Chem 277:21379–21388
Liu D, Dillon JS (2004) Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor. Steroids 69:279–289
Simoncini T, Mannella P, Fornari L, Varone G, Caruso A, Genazzani AR (2003) Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology 144:3449–3455
Traish AM, Kang HP, Saad F, Guay AT (2011) Dehydroepiandrosterone (DHEA) a precursor steroid or an active hormone in human physiology. J Sex Med 8:2960–2982
Goodwin B, Redinbo MR, Kliewer SA (2002) Regulation of cyp3a gene transcription by the pregnane X receptor. Annu Rev Pharmacol Toxicol 42:1–23
Kliewer SA, Goodwin B, Willson TM (2002) The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev 23:687–702
Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, Collins JL, Kliewer SA (2000) Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275:15122–15127
Ripp SL, Fitzpatrick JL, Peters JM, Prough RA (2002) Induction of CYP3A expression by dehydroepiandrosterone: involvement of the pregnane X receptor. Drug Metab Dispos 30:570–575
Straub RH, Konecna L, Hrach S, Rothe G, Kreutz M, Schölmerich J, Falk W, Lang B (1998) Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 83:2012–2017
Peters JM, Zhou YC, Ram PA, Lee SS, Gonzales FJ, Waxman DJ (1996) Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate. Mol Pharmacol 50:67–74
Poynter ME, Daynes RA (1998) Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J Biol Chem 273(32):833–841
Maurice T, Gregoire C, Espallergues J (2006) Neuro(active)steroids actions at the neuromodulatory sigma1 (sigma1) receptor: biochemical and physiological evidences, consequences in neuroprotection. Pharmacol Biochem Behav 84:581–597
Cheng ZX, Lan DM, Wu PY, Zhu YH, Dong Y, Ma L, Zheng P (2008) Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors. Exp Neurol 210:128–136
Tagashira H, Bhuiyan S, Shioda N, Fukunaga K (2011) Distinct cardioprotective effects of 17beta-estradiol and dehydroepiandrosterone on pressure overload-induced hypertrophy in ovariectomized female rats. Menopause 18:1317–1326
Bhuiyan MS, Tagashira H, Fukunaga K (2011) Dehydroepiandrosterone-mediated stimulation of sigma-1 receptor activates Akt–eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding. Cardiovasc Ther 29:219–230
Bhuiyan S, Fukunaga K (2010) Stimulation of Sigma-1 receptor by dehydroepiandrosterone ameliorates hypertension-induced kidney hypertrophy in ovariectomized rats. Exp Biol Med (Maywood) 235:356–564
Levy HR (1979) Glucose-6-phosphate dehydrogenases. Adv Enzymol Relat Areas Mol Biol 48:97–192
Schwartz AG, Pashko LL (2004) Dehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and longevity. Ageing Res Rev 3:171–187
Camporez JP, Akamine EH, Davel AP, Franci CR, Rossoni LV, Carvalho CR (2011) Dehydroepiandrosterone protects against oxidative stress-induced endothelial dysfunction in ovariectomized rats. J Physiol 589:2585–2596
Nheu L, Nazareth L, Xu GY, Xiao FY, Luo RZ, Komesaroff P, Ling S (2011) Physiological effects of androgens on human vascular endothelial and smooth muscle cells in culture. Steroids 76:1590–1596
Jacob MH, Janner Dda R, Bello-Klein A, Llesuy SF, Ribeiro MF (2008) Dehydroepiandrosterone modulates antioxidant enzymes and Akt signaling in healthy Wistar rat hearts. J Steroid Biochem Mol Biol 112:138–144
Jia C, Chen X, Li X, Li M, Miao C, Sun B, Fan Z, Ren L (2011) The effect of DHEA treatment on the oxidative stress and myocardial fibrosis induced by Keshan disease pathogenic factors. J Trace Elem Med Biol 25:154–159
Lasley BL, Crawford SL, Laughlin GA, Santoro N, McConnell DS, Crandall C, Greendale GA, Polotsky AJ, Vuga M (2011) Circulating dehydroepiandrosterone levels in women with bilateral Salpingo-oophorectomy during the menopausal transition. Menopause 18:494–498
Crawford S, Santoro N, Laughlin GA, Sowers MF, McConnell D, Sutton-Tyrrell K, Weiss G, Vuga M, Randolph J, Lasley B (2009) Circulating dehydroepiandrosterone sulfate concentrations during the menopausal transition. J Clin Endocrinol Metab 94:2945–2951
Valenti G, Denti L, Maggio M, Ceda G, Volpato S, Bandinelli S, Ceresini G, Cappola A, Guralnik JM, Ferrucci L (2004) Effect of DHEAS on skeletal muscle over the life span: the InCHIANTI study. J Gerontol Ser A Biol Sci Med Sci 59:466–472
Kostka T, Arsac LM, Patricot MC, Berthouze SE, Lacour JR, Bonnefoy M (2000) Leg extensor power and dehydroepiandrosterone sulfate, insulin-like growth factor-I and testosterone in healthy active elderly people. Eur J Appl Physiol 82:83–90
Ravaglia G, Forti P, Maioli F, Boschi F, Cicognani A, Bernardi M, Pratelli L, Pizzoferrato A, Porcu S, Gasbarrini G (1997) Determinants of functional status in healthy Italian nonagenarians and centenarians: a comprehensive functional assessment by the instruments of geriatric practice. J Am Geriatr Soc 45:1196–1202
Leng SX, Cappola AR, Anderson RE, Blackman MR, Koenig K, Blair M, Walston JD (2004) Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res 16:153–157
Voznesensky M, Walsh S, Dauser D, Brindisi J, Kenny AM (2009) The association between dehydroepiandosterone and frailty in older men and women. Age Ageing 38:401–406
Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, Faucounau V, Girard L, Hervy MP, Latour F, Leaud MC, Mokrane A, Pitti-Ferrandi H, Trivalle C, de Lacharrière O, Nouveau S, Rakoto-Arison B, Souberbielle JC, Raison J, Le Bouc Y, Raynaud A, Girerd X, Forette F (2000) Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge study to a sociobiomedical issue. Proc Nat Acad Natl Sci 97:4279–4284
Ohlsson C, Labrie F, Barrett-Connor E, Karlsson MK, Ljunggren O, Vandenput L, Mellström D, Tivesten A (2010) Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men. J Clin Endocrinol Metab 95:4406–4414
Kroboth PD, Salek FS, Pittenger AL, Fabian TJ, Frye RF (1999) DHEA and DHEA-S: a review. J Clin Pharmacol 39:327–348
Lois K, Kassi E, Prokopiou M, Chrousos GP (2014, June 18) Adrenal androgens and aging. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A (eds) Endotext [Internet]. MDText.com, Inc., South Dartmouth (MA), 2000-
McEwen BS, Albeck D, Cameron H, Chao HM, Gould E, Hastings N (1995) Stress and the brain: a paradoxical role for adrenal steroids. In: Litwack GD (ed) Vitamins and hormones. Academic Press, New York, pp 371–402
Galea LA, McEwen BS (1999) Sex and seasonal differences in the rate of cell proliferation in the dentate gyrus of adult meadow voles. Neuroscience 83:955–964
Gould E, McEwen BS, Tanapat P, Galea LAM, Fuchs E (1997) Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA. J Neurosci 17:2492–2498
Raz N, Rodrigue KM (2006) Differential aging of the brain: patterns, cognitive correlates and modifiers. Neurosci Biobehav Rev 30:730–748. [PubMed: 16919333]
Garrido P, Blas M. De, Gine E, Santos A and Mora F. (2012) Aging impairs the control of prefrontal cortex on the release of corticosterone in response to stress and on memory consolidation. Neurobiol Aging 33:827, e821–e829. [PubMed: 21794953]
Qu T, Uz T, Manev H (2000) Inflammatory 5-LOX mRNA and protein are increased in brain of aging rats. Neurobiol Aging 21:647–652
Zhang W, Lei ZM, Rao CV (1999) Immortalized hippocampal cells contain functional luteinizing hormone/human chorionic gonadotropin receptors. Life Sci 65:2083–2098
Sapolsky RM, Krey LC, McEwen BS (1986) The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 7:284–301
Conrad CD (2008) Chronic stress-induced hippocampal vulnerability: the glucocorticoid vulnerability hypothesis. Rev Neurosci 19:395–411
Acknowledgments
I would sincerely acknowledge Prof. Pramod C. Rath for the kind support and inspiration provided by him in compiling this chapter on the role of stress on the dysregulation of the HPA axis. I would also acknowledge the assistance provided by Mr. Lav Jaiswal in collection of the materials and literature necessary to compile this chapter. Finally, I would like to thank my family members, my mother Mrs. Chitralekha, my wife Mrs. Varsha, and my children Ishaan and Vaibhavi for their patience, cooperation, and support without which it would have been difficult to compile this chapter. Financial support by the DST-SERB in the form of DST Fast Track Young Scientist Project (Sanction Order No. SB/YS/LS-39/2013) is highly acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Gupta, A. (2019). Role of Stress and Hormones of the Hypothalamic-Pituitary-Adrenal (HPA) Axis in Aging. In: Rath, P. (eds) Models, Molecules and Mechanisms in Biogerontology. Springer, Singapore. https://doi.org/10.1007/978-981-13-3585-3_12
Download citation
DOI: https://doi.org/10.1007/978-981-13-3585-3_12
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-3584-6
Online ISBN: 978-981-13-3585-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)